Medication info
Clofigel Tablets (Clopidogrel Sulfate)

Clofigel Tablets (Clopidogrel Sulfate)

Prescription medicationTabletOral
Ingredient · strength
Clopidogrel Bisulfate›97.875mg / 1 tablet
Manufacturer / importer
Korea Union Pharmaceutical Co., Ltd.
Appearance
Pink round film-coated tablets
Packaging
30 tablets/bottle, 300 tablets/bottle
Approval status
Active

MFDS item code 200501427 · Approved 2005.10.26 · Insurance code 665504160

Summary

Main use
Improvement of symptoms of atherosclerosis and acute coronary syndrome; prevention of thromboembolism in atrial fibrillation
Who takes it
Adults
Adult dose
○ Adults 1. For patients with ischemic stroke, myocardial infarction, or peripheral arterial disease, administer clopidogrel 75 mg orally once daily. 2. For patients with acute coronary syndrome (unstable angina or non-Q-wave myocardial infarction), start with a loading dose of 300 mg of this medicine once daily on the day treatment is initiated, followed by a maintenance dose of 75 mg orally once daily. In this case, aspirin 75 ~ 325 mg should be administered once daily in combination with this medicine. 3. For patients with atrial fibrillation, administer 75 mg of this medicine orally once daily. In this case, aspirin 75 ~ 100 mg should be administered once daily in combination with this medicine. ○ Patients with renal impairment : Treatment experience in patients with renal impairment is limited. ○ Patients with hepatic impairment : Treatment experience in patients with moderate liver disease and a bleeding diathesis is limited. This medicine may be administered without regard to food.

Ingredients

Manufacturer
Korea Union Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of symptoms of atherosclerosis and acute coronary syndrome; prevention of thromboembolism in atrial fibrillation

  • Ischemic stroke
  • myocardial infarction
  • peripheral artery disease
  • acute coronary syndrome
  • unstable angina
  • non-Q-wave myocardial infarction
  • cardiovascular abnormalities
  • stroke
  • refractory ischemia
  • vascular risk factors
  • low bleeding risk in atrial fibrillation.
View approved original text

This medication is used to improve symptoms of atherosclerotic diseases such as ischemic stroke, myocardial infarction, and peripheral artery disease. It also helps alleviate symptoms related to death or stroke due to cardiovascular abnormalities in patients with acute coronary syndrome. In patients with atrial fibrillation who have vascular risk factors, it helps reduce the risk of stroke and thromboembolism, especially when vitamin K antagonists are unsuitable. This medication enhances cardiovascular health and decreases the risk of thrombosis, improving the patient's condition.

How to take

Adult dose

○ Adults 1. For patients with ischemic stroke, myocardial infarction, or peripheral arterial disease, administer clopidogrel 75 mg orally once daily. 2. For patients with acute coronary syndrome (unstable angina or non-Q-wave myocardial infarction), start with a loading dose of 300 mg of this medicine once daily on the day treatment is initiated, followed by a maintenance dose of 75 mg orally once daily. In this case, aspirin 75 ~ 325 mg should be administered once daily in combination with this medicine. 3. For patients with atrial fibrillation, administer 75 mg of this medicine orally once daily. In this case, aspirin 75 ~ 100 mg should be administered once daily in combination with this medicine. ○ Patients with renal impairment : Treatment experience in patients with renal impairment is limited. ○ Patients with hepatic impairment : Treatment experience in patients with moderate liver disease and a bleeding diathesis is limited. This medicine may be administered without regard to food.

Precautions

This medication prevents platelet aggregation in the blood, thereby preventing thrombosis. Since this medication must be converted into an active form in the liver to be effective, individuals with genetically reduced function of the enzyme CYP2C19 that activates this drug may experience diminished effectiveness. Moreover, taking this medication alongside drugs that activate the CYP2C19 enzyme can increase the concentration of active metabolites in the bloodstream, leading to an elevated bleeding risk, so concurrent use should be avoided. Individuals allergic to this medication or its components, those with active bleeding, severe liver damage, nursing mothers, or individuals with lactose intolerance should not take this medication. Patients at high risk for bleeding or those suspected of having bleeding symptoms should undergo blood tests to monitor their condition. Care is advised when taking this drug alongside anticoagulants like warfarin, as this can further increase the risk of bleeding. This medication may prolong bleeding time, leading to potential bleeding occurrences in the gastrointestinal tract or eyes; caution is advised for those with gastrointestinal ulcers or ocular lesions. Patients scheduled for surgery or with a history of trauma should discontinue this medication 5-7 days prior to surgery and resume only after hemostasis has been achieved. Concurrent use with other medications that pose a risk of bleeding (such as aspirin, non-steroidal anti-inflammatory drugs, heparin, thrombolytics, selective serotonin reuptake inhibitors) should be exercised with caution. Specifically, careful consideration should be given if a patient with a transient ischemic attack or stroke is taking both aspirin and this medication due to an increased risk of bleeding. Rare blood disorders such as thrombocytopenia or neutropenia may occur with this medication, so if symptoms of fever or infection develop, patients should consult a physician immediately. Gastrointestinal effects may include abdominal pain, dyspepsia, diarrhea, and allergic reactions such as skin rashes or itching have also been reported. It poses a low risk to the fetus during pregnancy; however, the risk of bleeding during delivery can increase, thus discontinuation 5-7 days before delivery is recommended. If breastfeeding, patients should consult with their doctor regarding the potential for this medication to be excreted in breast milk and whether to continue breastfeeding or cease medication. Safety and efficacy in children have yet to be established. Elderly individuals may have reduced renal and liver function, increasing bleeding risk, therefore careful dose adjustments and monitoring are required. In case of overdose, the bleeding risk can increase and there is no specific antidote; treatment may include platelet transfusion in cases of severe bleeding. This medication should be stored out of reach of children and should not be transferred to other containers. During the course of treatment, any suspected bleeding symptoms or adverse reactions should be immediately reported to healthcare personnel, and the healthcare provider should be informed of ongoing medication prior to surgery or the initiation of new medications.

Side effects

Hemorrhage, gastrointestinal bleeding, purpura, contusion, hematoma, epistaxis, hematoma, hematuria, intraocular hemorrhage, intracranial hemorrhage, neutropenia, agranulocytosis, aplastic anemia, thrombocytopenia, abdominal pain, dyspepsia, diarrhea, nausea, rash, pruritus, chest pain, accidental injury, influenza-like illness, pain, fatigue, edema, hypertension, headache, dizziness, depression, upper respiratory infection, respiratory distress, rhinitis, bronchitis, cough, urinary tract infection, syncope, palpitations, weakness, fever, hernia, heart failure, atrial fibrillation, leg cramps, sensory disturbance, neuralgia, paresthesia, vertigo, constipation, vomiting, elevated liver enzymes, gout, hyperuricemia, increased non-protein nitrogen, arthralgia, arthritis, anxiety, insomnia, anemia, pneumonia, sinusitis, eczema, skin ulcer, cystitis, cataract, conjunctivitis, gynecomastia, fever, abnormal liver function tests, increased blood creatinine, cholecystitis, hematemesis, spinal hematoma, allergic symptoms, ischemic necrosis, hemorrhagic arthropathy, hematuria syndrome, hemoptysis, thrombocytopenia, hypochromic anemia, leukemia, leukopenia, eosinophilia, menorrhagia, hemothorax, herpes zoster, erythema multiforme, papular urticaria, urticaria, renal dysfunction, acute renal failure, Kounis syndrome, anaphylaxis-like reaction, serum sickness, confusion, hallucinations, dysgeusia, loss of taste, vasculitis, hypotension, bronchospasm, interstitial pneumonia, eosinophilic pneumonia, colitis, pancreatitis, gastritis, stomatitis, hepatitis, acute liver failure, papular urticaria, urticaria, itching, angioedema, vesicular dermatitis, drug-induced hypersensitivity syndrome, drug rash with eosinophilia and systemic symptoms, lichen planus, arthritis, myalgia, glomerulonephritis, gynecomastia, elevated prostate-specific antigen, decreased motor function, tremor, voice disorder, abnormal gait, hyperactivity, ataxia, sensory disturbance, insomnia, depression, memory loss, stupor, abnormal thoughts, abnormal behavior, rigidity, facial edema, melena, muscle hemorrhage, gingival bleeding, visual disturbances, visual field defects, dry eyes, transient blindness, conjunctival injection, tinnitus, urinary dysfunction, polyuria, increased non-protein nitrogen, uremia, elevated blood urea nitrogen, hypoglycemia, hyperuricemia, elevated ALT, leg edema, arrhythmia, bradycardia, palpitations, contact dermatitis, elevated prostate-specific antigen

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to protect it from air and moisture, and it is advisable to keep it at room temperature between 1 to 30 degrees Celsius. Storing it this way helps maintain its effectiveness for a longer period.

Appearance and packaging

Appearance

Pink round film-coated tablets

Package unit

30 tablets/bottle, 300 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.